119 related articles for article (PubMed ID: 37873581)
1. Selective Inhibition of Hepatic Stellate Cell and Fibroblast-derived LOXL1 Attenuates BDL and Mdr2
Yan X; Zhang N; Wei L; Zhang W; Huang T; Li W; Chen W; Yang A; You H
Am J Physiol Gastrointest Liver Physiol; 2023 Oct; ():. PubMed ID: 37873581
[TBL] [Abstract][Full Text] [Related]
2. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
[TBL] [Abstract][Full Text] [Related]
5. Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation.
Li M; Zhou Y; Zhu H; Xu LM; Ping J
J Integr Med; 2024 Mar; 22(2):188-198. PubMed ID: 38472011
[TBL] [Abstract][Full Text] [Related]
6. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
[TBL] [Abstract][Full Text] [Related]
7. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.
Li J; Zhu X; Zhang M; Zhang Y; Ye S; Leng Y; Yang T; Kong L; Zhang H
J Hepatol; 2021 Aug; 75(2):400-413. PubMed ID: 33746084
[TBL] [Abstract][Full Text] [Related]
8. Selective depletion of hepatic stellate cells-specific LOXL1 alleviates liver fibrosis.
Yang A; Yan X; Xu H; Fan X; Zhang M; Huang T; Li W; Chen W; Jia J; You H
FASEB J; 2021 Oct; 35(10):e21918. PubMed ID: 34569648
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
[TBL] [Abstract][Full Text] [Related]
10. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.
Chen L; Zhou T; White T; O'Brien A; Chakraborty S; Liangpunsakul S; Yang Z; Kennedy L; Saxena R; Wu C; Meng F; Huang Q; Francis H; Alpini G; Glaser S
Hepatology; 2021 Jun; 73(6):2411-2428. PubMed ID: 32964473
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.
Yang A; Yan X; Fan X; Shi Y; Huang T; Li W; Chen W; Jia J; You H
Hepatol Int; 2021 Oct; 15(5):1122-1135. PubMed ID: 34014450
[TBL] [Abstract][Full Text] [Related]
12. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries.
Beaussier M; Wendum D; Schiffer E; Dumont S; Rey C; Lienhart A; Housset C
Lab Invest; 2007 Mar; 87(3):292-303. PubMed ID: 17260005
[TBL] [Abstract][Full Text] [Related]
13. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
[TBL] [Abstract][Full Text] [Related]
14. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
[TBL] [Abstract][Full Text] [Related]
15. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
17. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
18. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the
Fuchs CD; Sroda N; Scharnagl H; Gupta R; Minto W; Stojakovic T; Liles JT; Budas G; Hollenback D; Trauner M
JHEP Rep; 2023 Nov; 5(11):100874. PubMed ID: 37841639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]